Johnson & Johnson (JNJ) stock
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)
Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%
Johnson & Johnson enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Johnson & Johnson's enterprise value was $712.82B on Nov 11, 2026, against $529.05B a year earlier. Over the last 5 years it ranged from $366.57B to $712.82B, with a median of $444.60B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $712.82B | +34.7% |
| 2025 | Dec 31, 2025 | $529.12B | +44.3% |
| 2024 | Dec 31, 2024 | $366.57B | -11.7% |
| 2023 | Dec 29, 2023 | $415.26B | -11.5% |
| 2022 | Dec 30, 2022 | $469.02B | +1.9% |
| 2021 | Dec 31, 2021 | $460.09B | +7.7% |
| 2020 | Dec 31, 2020 | $427.13B | +5.6% |
| 2019 | Dec 31, 2019 | $404.63B | +11.1% |
| 2018 | Dec 31, 2018 | $364.29B | -9.6% |
| 2017 | Dec 29, 2017 | $403.15B | +30.6% |
| 2016 | Dec 30, 2016 | $308.67B | +13.4% |
| 2015 | Dec 31, 2015 | $272.30B | -9.7% |
| 2014 | Dec 31, 2014 | $301.67B | +15.8% |
| 2013 | Dec 31, 2013 | $260.50B | +32.3% |
| 2012 | Dec 31, 2012 | $196.94B | +6.1% |
| 2011 | Dec 30, 2011 | $185.63B | +8.1% |
| 2010 | Dec 31, 2010 | $171.79B | -4.3% |
| 2009 | Dec 31, 2009 | $179.51B | – |
See a number that looks wrong?